Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
Diagnosing a genetic kidney disease involves an investigative process. It moves from general clues to specific proof. Unlike a standard kidney infection that can be diagnosed with a simple urine culture, genetic nephrology requires looking at the patient’s entire history, their family tree, and their DNA. The goal is not just to name the disease but to understand its specific subtype, which dictates the best treatment and the risk to other family members.
The evaluation process is thorough. It often involves a team of specialists, including nephrologists, geneticists, genetic counselors, and sometimes audiologists or ophthalmologists. This multidisciplinary approach guarantees the inclusion of all aspects of the syndrome. This section outlines the journey from the first suspicion to the final genetic confirmation.
The investigation begins with a conversation. The doctor creates a detailed family tree (pedigree), asking about at least three generations.
They search for patterns: Did your grandfather have kidney failure? Did your mother have hearing loss? Are there any unexplained deaths in the family at a young age? This mapping helps determine the inheritance pattern (dominant, recessive, or X-linked).
The doctor performs a physical exam looking for “extra-renal” signs. They might check your skin for rashes associated with Fabry disease, examine your eyes for lens abnormalities, or check your hearing. They palpate the abdomen to feel for enlarged kidneys or liver. These physical clues can narrow down the list of thousands of possible genetic diseases to a manageable few.
To see what is happening inside the kidney, imaging is essential. An ultrasound is usually the first step because it is safe and radiation-free.
Ultrasound can easily show the large cysts of polycystic kidney disease. It can reveal if the kidneys are too small (hypoplastic) or if they are scarred (echogenic). It also checks the bladder and ureters for structural blockages.
For more detail, a CT scan or MRI might be ordered. These provide a high-definition map of the kidney’s architecture. They are particularly useful for measuring total kidney volume in PKD aids in forecasting the rate of disease progression. MRI is also used to examine for brain aneurysms, which can be associated with certain kidney genes.
Sometimes, looking at the tissue under a microscope is necessary. A kidney biopsy involves taking a tiny sample of kidney tissue with a needle.
This kind of procedure is less common now that genetic testing is better, but it is still valuable. It allows pathologists to see the specific type of damage to the filters. For example, using an electron microscope, they can see the “basket-weave” pattern in the filter’s membrane that is unique to Alport syndrome. Biopsy can also confirm the diagnosis of Fabry disease by showing fatty deposits in the cells. It helps distinguish genetic disease from other causes like autoimmune attacks.
The definitive diagnosis comes from DNA testing. Technology has evolved from testing one gene at a time to testing hundreds at once.
Doctors usually order a “Renal Genetics Panel.” This test looks at 300 to 400 genes known to cause kidney disease simultaneously. It is efficient and cost-effective. It looks for spelling errors (mutations) in the genetic code.
If the panel comes back negative but the suspicion is still high, the doctor might order whole exome sequencing. This procedure reads the coding regions of all 20,000 genes in the body. It is a broad search used for complex or rare cases that don’t fit the standard patterns. It can discover new or extremely rare mutations that a standard panel would miss.
Regardless of the genetic cause, measuring how well the kidneys are working is standard.
Doctors rely on the Glomerular Filtration Rate (GFR), calculated from the blood creatinine level. This number (like a percentage) tells us how much kidney function remains. Tracking GFR over time shows the “slope” of decline, helping doctors predict when dialysis might be needed years in the future.
Measuring the exact amount of protein in the urine is crucial. Whether it is 500 mg or 5 grams a day matters. High protein loss indicates active damage and high risk of progression. Reducing this number is often a primary goal of treatment.
A diagnosis affects the whole family. Genetic counseling is a vital part of the evaluation. Counselors explain what the test results mean in plain language.
They help patients navigate the emotional weight of a genetic diagnosis. They discuss the risks for children and siblings and facilitate “cascade screening,” where family members are tested in a logical order. They also discuss reproductive options, such as pre-implantation genetic testing (PGD) for couples who want to ensure their children do not inherit the condition.
Liv Hospital Vadistanbul
Prof. MD. Süleyman Tevfik Ecder
Nephrology
Liv Hospital Bahçeşehir
Asst. Prof. MD. Himmet Bora Uslu
Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Mehmet Taşdemir
Pediatric Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Ozan Özkaya
Pediatric Nephrology
Liv Hospital Ankara
Prof. MD. Hüsnü Oğuz Söylemezoğlu
Pediatric Nephrology
Liv Bona Dea Hospital Bakü
MD. FERHAD ŞİRİNOV
Nephrology
Send us all your questions or requests, and our expert team will assist you.
It can be, but costs have dropped significantly. Many insurance plans cover it, and there are sponsored testing programs for certain diseases like Alport syndrome or Fabry disease that offer free testing.
This is called a “Variant of Uncertain Significance” (VUS). It means a change was found, but we don’t know if it causes disease. Doctors use family testing and computer models to try to figure it out over time.
Genetic discrimination laws protect health insurance in some countries, but they may affect life insurance and disability insurance. It is often advised to secure these policies before testing.
Often, no. If the genetic test is positive and matches your symptoms, you can usually avoid the invasive biopsy. Biopsy is saved for cases where the genetic answer is unclear.
Results typically take 4 to 8 weeks to return, as the analysis of the DNA data is complex and requires careful review by geneticists.
BlogGenetic NephrologyMay 12, 2026Hypoplasia of the kidney affects kidney size and function from birth. We provide compassionate diagnosis an...
BlogGenetic NephrologyMay 08, 2026Is ckd hereditary? We explore genetic risks, family history, and how inherited factors influence chronic ki...
BlogGenetic NephrologyApr 13, 2026Pyruvate kinase deficiency (pk disease) is a rare genetic disorder affecting red blood cells. Learn about t...
BlogGenetic NephrologyApr 13, 2026Huntington's disease follows an autosomal dominant inheritance pattern, with a 50% chance of passing the al...
BlogGenetic NephrologyApr 13, 2026Explore the key HD symptoms and understand the genetic basis of this fatal neurodegenerative disorder.
BlogGenetic NephrologyApr 09, 2026Uncover the genetic connection to kidney disease. Learn about your risk factors and family history.
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 67 91